• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DAI Lili,SU Zhigui,ZHANG Can.Research progress on nanomedicine delivery systems in targeting atherosclerosis[J].Journal Of Pharmaceutical Research,2017,36(8):471-476[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3413times   Download 3651次 QR Code for this article
Scan with your phone!
纳米药物递送系统靶向动脉粥样硬化斑块的研究进展
戴丽丽,苏志桂,张灿
Font:Larger+|Default|Smaller-
(中国药科大学天然药物活性组分与药效国家重点实验室,江苏 南京 210009)
摘要:
心血管疾病是全球死亡率最高的疾病,而动脉粥样硬化是心血管疾病主要诱因。鉴于常规的给药方式,进入斑块的药物浓度很低,难以实现直接针对斑块的有效治疗策略。纳米药物递送系统在靶向斑块、斑块局部释放药物和提高斑块内药物有效浓度等方面具有显著优势,为动脉粥样硬化的诊断、治疗和疗效评估等提供了切实可行的方法和技术平台。本文从靶向递送策略的角度对近年来针对动脉粥样硬化斑块的纳米药物递送系统进行综述,为纳米药物递送系统应用于动脉粥样硬化诊疗的设计和构建提供参考。
关键词:  动脉粥样硬化  纳米药物递送系统  靶向治疗  斑块
DOI:10.13506/j.cnki.jpr.2017.08.011
基金项目:国家自然科学基金(No.81503006、BK20150698、81473153)
Research progress on nanomedicine delivery systems in targeting atherosclerosis
DAI Lili,SU Zhigui,ZHANG Can
(State Key Laboratory of active ingredients and efficacy of natural drugs, China Pharmaceutical University,Nanjing 210009,China)
Abstract:
Cardiovascular disease occupies the highest mortality rates in the world.Atherosclerosis (AS) is the major cause of cardiovascular disease.For traditional administration method,the concentration of drug in in the AS plaque is low,which would be difficult to implement the curative effect in plaque.As known to everyone, compared to traditional small molecule drugs,nanomedicine delivery systems possess the capacities of targeting AS plaque,triggering drug release and elevating the effective concentration of drugs in AS plaque,which would provide a potential platform and technology for diagnosis,treatment,and integration of diagnosis and treatment of AS therapy.In this paper,recently nanomedicine delivery systems for targeting AS plaque were reviewed in the angle of targeting strategy,which was aimed to provide reference to reasonable design and construct novel nanomedicine delivery systems.
Key words:  Atherosclerosis  Nanomedicine delivery systems  Targeted therapy  Plaque
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.